These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16554307)

  • 1. Amyloid fibrils of mammalian prion protein are highly toxic to cultured cells and primary neurons.
    Novitskaya V; Bocharova OV; Bronstein I; Baskakov IV
    J Biol Chem; 2006 May; 281(19):13828-13836. PubMed ID: 16554307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Prion Protein Binds Isolated Low Molecular Weight Amyloid-β Oligomers Causing Cytotoxicity Inhibition.
    Williams TL; Choi JK; Surewicz K; Surewicz WK
    ACS Chem Neurosci; 2015 Dec; 6(12):1972-80. PubMed ID: 26466138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
    Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
    Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo neurotoxicity of prion protein oligomers.
    Simoneau S; Rezaei H; Salès N; Kaiser-Schulz G; Lefebvre-Roque M; Vidal C; Fournier JG; Comte J; Wopfner F; Grosclaude J; Schätzl H; Lasmézas CI
    PLoS Pathog; 2007 Aug; 3(8):e125. PubMed ID: 17784787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular structure of amyloid fibrils controls the relationship between fibrillar size and toxicity.
    Lee YJ; Savtchenko R; Ostapchenko VG; Makarava N; Baskakov IV
    PLoS One; 2011; 6(5):e20244. PubMed ID: 21625461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assemblages of prion fragments: novel model systems for understanding amyloid toxicity.
    Satheeshkumar KS; Murali J; Jayakumar R
    J Struct Biol; 2004 Nov; 148(2):176-93. PubMed ID: 15477098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Globular and pre-fibrillar prion aggregates are toxic to neuronal cells and perturb their electrophysiology.
    Sanghera N; Wall M; Vénien-Bryan C; Pinheiro TJ
    Biochim Biophys Acta; 2008 Jun; 1784(6):873-81. PubMed ID: 18374666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
    Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
    J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elongated oligomers assemble into mammalian PrP amyloid fibrils.
    Tattum MH; Cohen-Krausz S; Thumanu K; Wharton CW; Khalili-Shirazi A; Jackson GS; Orlova EV; Collinge J; Clarke AR; Saibil HR
    J Mol Biol; 2006 Mar; 357(3):975-85. PubMed ID: 16473369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
    Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
    J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
    Baskakov IV; Bocharova OV
    Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid features and neuronal toxicity of mature prion fibrils are highly sensitive to high pressure.
    El Moustaine D; Perrier V; Acquatella-Tran Van Ba I; Meersman F; Ostapchenko VG; Baskakov IV; Lange R; Torrent J
    J Biol Chem; 2011 Apr; 286(15):13448-59. PubMed ID: 21357423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein misfolding cyclic amplification induces the conversion of recombinant prion protein to PrP oligomers causing neuronal apoptosis.
    Yuan Z; Yang L; Chen B; Zhu T; Hassan MF; Yin X; Zhou X; Zhao D
    J Neurochem; 2015 Jun; 133(5):722-9. PubMed ID: 25810062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different structural stability and toxicity of PrP(ARR) and PrP(ARQ) sheep prion protein variants.
    Paludi D; Thellung S; Chiovitti K; Corsaro A; Villa V; Russo C; Ianieri A; Bertsch U; Kretzschmar HA; Aceto A; Florio T
    J Neurochem; 2007 Dec; 103(6):2291-300. PubMed ID: 17919292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly neurotoxic monomeric α-helical prion protein.
    Zhou M; Ottenberg G; Sferrazza GF; Lasmézas CI
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3113-8. PubMed ID: 22323583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
    Baskakov IV
    J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanin rescues cortical neurons from prion-peptide-induced apoptosis.
    Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Pillot T
    Mol Cell Neurosci; 2004 Jan; 25(1):95-102. PubMed ID: 14962743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the structural core and of conformational heterogeneity during the conversion of oligomers of the mouse prion protein to worm-like amyloid fibrils.
    Singh J; Sabareesan AT; Mathew MK; Udgaonkar JB
    J Mol Biol; 2012 Oct; 423(2):217-31. PubMed ID: 22789566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methionine oxidation interferes with conversion of the prion protein into the fibrillar proteinase K-resistant conformation.
    Breydo L; Bocharova OV; Makarava N; Salnikov VV; Anderson M; Baskakov IV
    Biochemistry; 2005 Nov; 44(47):15534-43. PubMed ID: 16300402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.